These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 10962646)
1. Can absolute oral bioavailability in humans be predicted from animals? A comparison of allometry and different indirect methods. Mahmood I Drug Metabol Drug Interact; 2000; 16(2):143-55. PubMed ID: 10962646 [TBL] [Abstract][Full Text] [Related]
2. Towards a better prediction of peak concentration, volume of distribution and half-life after oral drug administration in man, using allometry. Sinha VK; Vaarties K; De Buck SS; Fenu LA; Nijsen M; Gilissen RA; Sanderson W; Van Uytsel K; Hoeben E; Van Peer A; Mackie CE; Smit JW Clin Pharmacokinet; 2011 May; 50(5):307-18. PubMed ID: 21456631 [TBL] [Abstract][Full Text] [Related]
3. Predicting oral clearance in humans: how close can we get with allometry? Sinha VK; De Buck SS; Fenu LA; Smit JW; Nijsen M; Gilissen RA; Van Peer A; Lavrijsen K; Mackie CE Clin Pharmacokinet; 2008; 47(1):35-45. PubMed ID: 18076217 [TBL] [Abstract][Full Text] [Related]
4. PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 3: comparative assessement of prediction methods of human clearance. Ring BJ; Chien JY; Adkison KK; Jones HM; Rowland M; Jones RD; Yates JW; Ku MS; Gibson CR; He H; Vuppugalla R; Marathe P; Fischer V; Dutta S; Sinha VK; Björnsson T; Lavé T; Poulin P J Pharm Sci; 2011 Oct; 100(10):4090-110. PubMed ID: 21541938 [TBL] [Abstract][Full Text] [Related]
5. Drug disposition viewed in terms of the fractal volume of distribution. Karalis V; Macheras P Pharm Res; 2002 May; 19(5):696-703. PubMed ID: 12069175 [TBL] [Abstract][Full Text] [Related]
6. Prediction of human pharmacokinetic parameters using animal data and principles of allometry. A case using bicifadine, a non-narcotic analgesic, as an example. Srinivas NR; Ahlawat P Arzneimittelforschung; 2009; 59(12):625-30. PubMed ID: 20108647 [TBL] [Abstract][Full Text] [Related]
7. PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 4: prediction of plasma concentration-time profiles in human from in vivo preclinical data by using the Wajima approach. Vuppugalla R; Marathe P; He H; Jones RD; Yates JW; Jones HM; Gibson CR; Chien JY; Ring BJ; Adkison KK; Ku MS; Fischer V; Dutta S; Sinha VK; Björnsson T; Lavé T; Poulin P J Pharm Sci; 2011 Oct; 100(10):4111-26. PubMed ID: 21480234 [TBL] [Abstract][Full Text] [Related]
8. Human pharmacokinetic prediction of UDP-glucuronosyltransferase substrates with an animal scale-up approach. Deguchi T; Watanabe N; Kurihara A; Igeta K; Ikenaga H; Fusegawa K; Suzuki N; Murata S; Hirouchi M; Furuta Y; Iwasaki M; Okazaki O; Izumi T Drug Metab Dispos; 2011 May; 39(5):820-9. PubMed ID: 21282406 [TBL] [Abstract][Full Text] [Related]
9. Prediction of clearance and volume of distribution in the obese from normal weight subjects: an allometric approach. Mahmood I Clin Pharmacokinet; 2012 Aug; 51(8):527-42. PubMed ID: 22671778 [TBL] [Abstract][Full Text] [Related]
10. Preclinical pharmacokinetics and interspecies scaling of ragaglitazar, a novel biliary excreted PPAR dual activator. Pavankuamr VV; Vinu CA; Mullangi R; Srinivas NR Eur J Drug Metab Pharmacokinet; 2007; 32(1):29-37. PubMed ID: 17479541 [TBL] [Abstract][Full Text] [Related]
11. Prediction of Human Pharmacokinetics of Ulixertinib, a Novel ERK1/2 Inhibitor from Mice, Rats, and Dogs Pharmacokinetics. Suresh PS; Jairam RK; Chandrasekhar DV; Vinod AB; Hiremath RA; Raj A; Zainuddin M; Bhamidipati RK; Mullangi R Eur J Drug Metab Pharmacokinet; 2018 Aug; 43(4):453-460. PubMed ID: 29470718 [TBL] [Abstract][Full Text] [Related]
12. Interspecies scaling: predicting volumes, mean residence time and elimination half-life. Some suggestions. Mahmood I J Pharm Pharmacol; 1998 May; 50(5):493-9. PubMed ID: 9643442 [TBL] [Abstract][Full Text] [Related]
13. Prediction of human pharmacokinetics from preclinical information: comparative accuracy of quantitative prediction approaches. Hosea NA; Collard WT; Cole S; Maurer TS; Fang RX; Jones H; Kakar SM; Nakai Y; Smith BJ; Webster R; Beaumont K J Clin Pharmacol; 2009 May; 49(5):513-33. PubMed ID: 19299532 [TBL] [Abstract][Full Text] [Related]
14. Allometric issues in drug development. Mahmood I J Pharm Sci; 1999 Nov; 88(11):1101-6. PubMed ID: 10564055 [TBL] [Abstract][Full Text] [Related]
15. Application of allometric principles for the prediction of pharmacokinetics in human and veterinary drug development. Mahmood I Adv Drug Deliv Rev; 2007 Sep; 59(11):1177-92. PubMed ID: 17826864 [TBL] [Abstract][Full Text] [Related]
16. Prediction of human pharmacokinetics--evaluation of methods for prediction of hepatic metabolic clearance. Fagerholm U J Pharm Pharmacol; 2007 Jun; 59(6):803-28. PubMed ID: 17637173 [TBL] [Abstract][Full Text] [Related]
17. A global examination of allometric scaling for predicting human drug clearance and the prediction of large vertical allometry. Tang H; Mayersohn M J Pharm Sci; 2006 Aug; 95(8):1783-99. PubMed ID: 16795013 [TBL] [Abstract][Full Text] [Related]
18. A single-species approach considering additional physiological information for prediction of hepatic clearance of glycoprotein derivate therapeutics. Poulin P Clin Pharmacokinet; 2011 Oct; 50(10):665-74. PubMed ID: 21895038 [TBL] [Abstract][Full Text] [Related]
19. Prediction of Clearance, Volume of distribution, and Half-life of Drugs in Extremely Low to Low Birth Weight Neonates: An Allometric Approach. Mahmood I Eur J Drug Metab Pharmacokinet; 2017 Aug; 42(4):601-610. PubMed ID: 27562171 [TBL] [Abstract][Full Text] [Related]
20. Allometric pharmacokinetic scaling: towards the prediction of human oral pharmacokinetics. Feng MR; Lou X; Brown RR; Hutchaleelaha A Pharm Res; 2000 Apr; 17(4):410-8. PubMed ID: 10870984 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]